北京协和医院老年肿瘤患者综合评估的共识建议

doi:10.16352/j.issn.1001-6325.2025.09.1122

基础医学与临床 ›› 2025, Vol. 45 ›› Issue (9): 1122-1131.doi: 10.16352/j.issn.1001-6325.2025.09.1122

北京协和医院老年肿瘤患者综合评估的共识建议

王秋梅^1#, 李孝远^2#, 康琳¹, 孙晓红¹, 李海龙³, 段艳平⁴, 刘颖⁵, 管梅^2*, 赵林^2*

中国医学科学院北京协和医学院北京协和医院 1.老年医学科; 2.肿瘤内科; 3.临床营养科; 4.心理医学科; 5.康复医学科,北京 100730

收稿日期:2025-04-14 修回日期:2025-07-07 出版日期:2025-09-05 发布日期:2025-08-27
通讯作者: ^*guanmei@pumch.cn;zhaolin4412@pumch.cn
作者简介:^#对本文有相同贡献
基金资助:
北京协和医院中央高水平医院临床研究专项(2022-PUMCH-B-049)

Consensus recommendation on Comprehensive Geriatric Assessment for elderly cancer patients from Peking Union Medical College Hospital

WANG Qiumei^1#, LI Xiaoyuan^2#, KANG Lin¹, SUN Xiaohong¹, LI Hailong³, DUAN Yanping⁴, LIU Ying⁵, GUAN Mei^2*, ZHAO Lin^2*

1. Department of Geriatric Medicine; 2. Department of Medical Oncology; 3. Department of Clinical Nutrition; 4. Department of Psychological Medicine; 5. Department of Physical Rehabilitation,Peking Union Medical College Hospital, CAMS & PUMC, Beijing 100730, China

Received:2025-04-14 Revised:2025-07-07 Online:2025-09-05 Published:2025-08-27
Contact: ^*guanmei@pumch.cn;zhaolin4412@pumch.cn

摘要/Abstract

摘要： 在老龄化社会背景下,老年肿瘤患者的数量不断增加。老年肿瘤学近年来得到了广泛关注。根据老年人健康状态进行个体化的诊断、治疗、随诊以及护理变得越来越重要,因此,必须要强调对患者进行老年综合评估(CGA),包括老年人的躯体机能、营养状况、认知功能、情绪状态、共病情况、多重用药、社会状况以及诊疗意愿等。本文针对老年肿瘤治疗相关的老年综合评估提出共识建议,为国内的临床实践提供参考。

关键词: 老年综合评估(CGA), 肿瘤, 衰弱

Abstract: In the context of an aging society, the number of elderly cancer patients is constantly increasing, and geriatric oncology has garnered significant attention in recent years. Given the heterogeneity in the health status of older patients, it has become increasingly important to provide individualized diagnosis, treatment, follow-up, and care. Thus, it must be emphasized the Comprehensive Geriatric Assessment (CGA) for elderly patients, which encompasses their physical function, nutritional status, cognitive function, emotional state, comorbidities, polypharmacy, social situation, and treatment preferences. This article provides consensus recommendations on CGA tools for elderly patients prior to anticancer treatment, offering valuable references and insights for clinical practice in China.

Key words: Comprehensive Geriatric Assessment (CGA), cancer, frailty

中图分类号:

R73
R592

王秋梅, 李孝远, 康琳, 孙晓红, 李海龙, 段艳平, 刘颖, 管梅, 赵林. 北京协和医院老年肿瘤患者综合评估的共识建议[J]. 基础医学与临床, 2025, 45(9): 1122-1131.

WANG Qiumei, LI Xiaoyuan, KANG Lin, SUN Xiaohong, LI Hailong, DUAN Yanping, LIU Ying, GUAN Mei, ZHAO Lin. Consensus recommendation on Comprehensive Geriatric Assessment for elderly cancer patients from Peking Union Medical College Hospital[J]. Basic & Clinical Medicine, 2025, 45(9): 1122-1131.

参考文献 38

[1]	Han BF,Zheng RS,Zeng HM,et al.Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent,2024, 4:47-53.doi:10.1016/j.jncc.2024.01.006.eCollection 2024 Mar.
[2]	陈旭娇,严静,王建业,等.老年综合评估技术应用中国专家共识[J].中华老年医学杂志,2017, 36:471-477.
[3]	Corre R, Greillier L, Le Caër H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA GFPC-GECP 08-02 study[J]. J Clin Oncol, 2016, 34: 1476-1483. doi:10.1200/JCO.2015.63.5839.
[4]	Hamaker ME, Seynaeve C, Wymenga AN, et al. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists′ group[J]. Breast, 2014, 23: 81-87. doi:10.1016/j.breast.2013.11.004.
[5]	Anwar MR,Yeretzian ST, Ayala AP,et al.Effectiveness of geriatric assessment and management in older cancer patients: a systematic review and meta-analysis[J].J Natl Cancer Inst,2023,115:1483-1496. doi:10.1093/jnci/djad200.
[6]	Cesari M,Araujo DC, Amuthavalli T,et al. Evidence for the domains supporting the construct of intrinsic capacity[J].J Gerontol A Biol Sci Med Sci, 2018,73:1653-1660. doi:10.1093/gerona/gly011.
[7]	Veronese N, Custodero C, Cella A,et al.Prevalence of multidimensional frailty and pre-frailty in older people in different settings[J].Ageing Res Rev,2021,72:101498.doi:10.1016/j.arr.2021.101498.Epub 2021 Oct 23.
[8]	Ditzel HM, Giger AW, Lund CM, et al. Association between Geriatric 8 frailty and health-related quality of life in older patients with cancer (PROGNOSIS-G8): a Danish single-centre, prospective cohort study[J]. Lancet Healthy Longev, 2024,5:100612. doi:10.1016/S2666-7568(24)00118-1. Epub 2024 Aug 29.
[9]	Handforth C, Clegg A, Young C, et al. The prevalence and outcomes of frailty in older cancer patients: a systematic review[J]. Ann Oncol,2015,26:1091-1101. doi:10.1093/annonc/mdu540.
[10]	Ethun CG, Bilen MA, Jani AB,et al.Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology[J]. CA Cancer J Clin, 2017,67:362-377. doi:10.3322/caac.21406.
[11]	Jespersen E, Winther SB, Minet LR,et al. Shorter overall survival in older patients with gastrointestinal cancer receiving palliative chemotherapy-a prospective, clinical study[J]. J Geriatr Oncol, 2021,12:578-584. doi:10.1016/j.jgo.2020.10.007.
[12]	Narasimhulu DM, McGree ME, Weaver AL, et al. Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer[J]. Gynecol Oncol, 2020,158:646-652. doi:10.1016/j.ygyno.2020.05.04612.
[13]	Ribeiro AR, Howlett SE, Fernandes A. Frailty-A promising concept to evaluate disease vulnerability[J]. Mech Ageing Dev, 2020,187:111217. doi:10.1016/j.mad.2020.111217.
[14]	Shaw JF, Budiansky D, Sharif F, et al. The association of frailty with outcomes after cancer surgery: a systematic review and metaanalysis[J]. Ann Surg Oncol, 2022,29:4690-4704. doi:10.1245/s10434-021-11321-2.
[15]	International Society of Geriatrie Oncology (SIOG). Comprehensive geriatric assessment. Available from: https://siog.org/resources/resources-siog/comprehensive-geriatric-assessment/. Accessed November 6, 2022.
[16]	Wildiers H, Heeren P, Puts M, et al. International society of geriatric oncology consensus on geriatric assessment in older patients with cancer[J]. J Clin Oncol, 2014,32:2595-2603. doi:10.1200/JCO.2013.54.8347.
[17]	Mohile SG, Dale W, Somerfield MR, et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology[J]. J Clin Oncol, 2018,36:2326-2347. doi:10.1200/JCO.2018.78.8687.
[18]	Goede V.Frailty and cancer: current perspectives on assessment and monitoring[J].Clin Interv Aging, 2023,18:505-521. doi:10.2147/CIA.S365494. eCollection 2023.
[19]	Garcia MV, Agar MR, Soo WK, et al. Screening tools for identifying older adults with cancer who may benefit from a geriatric assessment: a systematic review[J]. JAMA Oncol, 2021,7:616-627. doi:10.1001/jamaoncol.2020.6736.
[20]	Almatrafi A, Gabe R, Beeken RJ,et al.Impact of frailty and comorbidity on initial response to lung cancer screening invitation and low-dose CT screening uptake: Findings from the Yorkshire Lung Screening Trial[J].J Med Screen, 2025:9691413251315087. doi:10.1177/09691413251315087. Online ahead of print.
[21]	Hinojo C, Cantos B, Antolin S,et al.Identification and management of medical comorbidities in patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: literature review and recommendations from experts in spain opinion[J].Clin Breast Cancer, 2024:S1526-8209(24)00367-7. doi:10.1016/j.clbc.2024.12.016. Online ahead of print.
[22]	McDonagh J, Lindley RI, Byth K,et al. Frailty in older adults admitted to hospital: outcomes from the Western Sydney Clinical Frailty Registry[J].BMC Geriatr, 2025,25:78. doi:10.1186/s12877-025-05715-0.
[23]	Cai PP, Gu LL,Wang X,et al.A single-center prospective cohort study assessing preoperative gait speed assessment as a prognostic tool for morbidity and mortality in frail elderly patients undergoing abdominal surgery[J].Braz J Med Biol Res, 2025,58:e14103. doi:10.1590/1414-431X2024e14103. eCollection 2025.
[24]	Tariq A, Alireza S,Zadeh M,et,al.Relationship between multiple morbidities and performance on the Timed Up and Go test in elderly patients: a cross-sectional study[J].BMJ Open,2025,15:e088950. doi:10.1136/bmjopen-2024-088950.
[25]	Schmidt AM,Kristensen HN,Melgaard D,et al. Development of a screening intervention for dysphagia in hospitalised geriatric patients.[J]. Dysphagia, 2025,30. doi:10.1007/s00455-025-10803-9. Online ahead of print.
[26]	Yuan GY, Ye GX, Hu JG,et al.Nomogram to screen older adult patients attending the radiology department for sarcopenia[J].BMC Geriatr, 2025,25:69. doi:10.1186/s12877-025-05730-1.
[27]	Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus updated on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020,21:300-307.e2. doi:10.1016/j.jamda.2019.12.012.
[28]	Bruijnen CP,van Harten-Krouwel DG,Koldenhof JJ,et al. Predictive value of each geriatric assessment domain for older patients with cancer: a systematic review[J]. J Geriatr Oncol, 2019,10:859-873. doi:10.1016/j.jgo.2019.02.010.
[29]	Stypulkowski K, Rodrigues J, Cieri F,et al.Comparison of the beck anxiety inventory and the geriatric anxiety scale in an older adult neurology clinic sample[J].Arch Clin Neuropsychol, 2025,4:acaf006. doi:10.1093/arclin/acaf006. Online ahead of print.
[30]	Park YS,Yoo K,KimHJ,et al.Association between sarcopenia components and depressed mood varies by sex among community-dwelling older adults from the Korean Frailty and Aging Cohort Study[J].Sci Rep,2025,15:3987.doi:10.1038/s41598-025-88437-y.
[31]	Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer[J]. J Clin Oncol, 2008, 26:2925-2926.
[32]	Mohamed MR, Rich DQ, Seplaki C, et al. Primary treatment modification and treatment tolerability among older chemotherapy recipients with advanced cancer[J].JAMA Netw Open,2024,7:e2356106.doi:10.1001/jamanetworkopen.2023.56106.
[33]	Tucci A, Ferrari S, Bottelli C et al. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy[J].Cancer, 2009,115:4547-4553. doi:10.1002/cncr.24490.
[34]	Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study[J]. J Clin Oncol, 2011,29:3457-3463. doi:10.1200/JCO.2011.34.7625.
[35]	Hurria A, Mohile S, Gajra A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer[J]. J Clin Oncol,2016,34:2366-2371. doi:10.1200/JCO.2015.65.4327.
[36]	Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score[J]. Cancer, 2012,118:3377-3386. doi:10.1002/cncr.26646.
[37]	Ortland I, Ott MM, Kowar M, et al. Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer[J]. J Geriatr Oncol, 2020,11:997-1005. doi:10.1016/j.jgo.2019.12.016.
[38]	Pang A, Low JL, Ng A, et al. Use of the cancer and aging research group predictive model for chemotherapy-related toxic effects in a multiethnic, older adult Asian population[J]. JAMA Netw Open, 2022,5:e2237196. doi:10.1001/jamanetworkopen.2022.37196.

北京协和医院老年肿瘤患者综合评估的共识建议

Consensus recommendation on Comprehensive Geriatric Assessment for elderly cancer patients from Peking Union Medical College Hospital

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 38

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王阳阳, 刘阳, 赵涵, 王薇. 老年综合评估在老年癌症患者中应用的现状及启示[J]. 基础医学与临床, 2025, 45(9): 1132-1138.
[2]	周慧聪, 邵亚娟. 老年肿瘤微环境对免疫检查点抑制剂治疗的影响[J]. 基础医学与临床, 2025, 45(9): 1139-1143.
[3]	凌彩霞, 王春芳, 罗艳红. TMEM基因家族在肿瘤发生发展中的作用[J]. 基础医学与临床, 2025, 45(9): 1243-1247.
[4]	龙丽娟, 宋松泽, 叶棋浓, 蔺静. LSD1调控肿瘤免疫机制的研究进展[J]. 基础医学与临床, 2025, 45(8): 1088-1092.
[5]	秦怡, 王晓燕. 蛋白酪氨酸激酶-2在妇科肿瘤中的作用[J]. 基础医学与临床, 2025, 45(8): 1098-1102.
[6]	罗浩君, 孔德欣, 黄薇, 杨楠, 刘雁勇. 基于Hsp90的荧光分子探针的构建与胰腺肿瘤识别效应评价[J]. 基础医学与临床, 2025, 45(7): 905-911.
[7]	王大亚, 李志家, 赵德威, 陈熙猛. MMSN@Gem的构建及其抑制人膀胱癌细胞系BIU-87增殖和促凋亡[J]. 基础医学与临床, 2025, 45(6): 777-785.
[8]	郭安静, 陈翀, 罗云萍. PRTN3调控巨噬细胞表型及其抗肿瘤作用的初步研究[J]. 基础医学与临床, 2025, 45(6): 701-708.
[9]	史立洲, 韩玮, 沈晓军. 核多聚腺苷酸结合蛋白1在肿瘤中的作用[J]. 基础医学与临床, 2025, 45(6): 822-828.
[10]	曹金金, 杜娟, 瞿姗娜, 朱明宇, 汪洋, 胡翰, 刘滨磊. 多靶点CAR-T细胞疗法在急性B淋巴细胞白血病中的应用[J]. 基础医学与临床, 2025, 45(5): 675-680.
[11]	李云帆, 邹佳铭, 王钰铖, 鞠瑞, 郭磊. CTO抑制小鼠胶质瘤细胞原位生长并调节相关小胶质细胞代谢及炎性表型[J]. 基础医学与临床, 2025, 45(4): 478-485.
[12]	王丽宁, 刘红刚. 鼻腔鼻窦恶性黑色素瘤临床病理特征及其与肿瘤浸润淋巴细胞亚群的相关性[J]. 基础医学与临床, 2025, 45(4): 527-531.
[13]	张大坤, 张洪波, 董德鑫, 高翔, 孟强, 高纪元. 肾脏上皮样血管平滑肌脂肪瘤临床特点[J]. 基础医学与临床, 2025, 45(3): 375-377.
[14]	楼海均, 孟·孟根, 张振宇, 童卓云, 乌都木丽. 跨膜蛋白33在肿瘤发生发展中的作用[J]. 基础医学与临床, 2025, 45(2): 258-262.
[15]	吴慧珊, 廖颖萍, 李萌. 衰弱患者氨基酸代谢特征的研究进展[J]. 基础医学与临床, 2025, 45(2): 253-257.